Yoshio Marumoto
- Hepatology top 2%
- Liver physiology and pathology 5
- Hepatitis C virus research 2
- Genetics top 5%
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 6
- Adipokines, Inflammation, and Metabolic Diseases 1
- Surgery top 10%
- Pancreatic function and diabetes 4
- Cholesterol and Lipid Metabolism 1
-
- Cancer Mechanisms and Therapy 2
-
- Fibroblast Growth Factor Research 2
- Co-authors
- Isao SakaidaShuji TeraiTsuyoshi IshikawaYohei UrataKoji AoyamaKiwamu OkitaTakahiro YamasakiKoichi Uchida
- Cited by
- HepatologyGeneticsEpidemiology
- Journals
- PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)Stem Cells (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Yoshio Marumoto
11 papers receiving 657 citations
Peers
Comparison fields: 5 of 63
- Hepatology 396
- Genetics 197
- Epidemiology 263
- Surgery 317
- Cell Biology 43
Countries citing papers authored by Yoshio Marumoto
This map shows the geographic impact of Yoshio Marumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Marumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Marumoto more than expected).
Fields of papers citing papers by Yoshio Marumoto
This network shows the impact of papers produced by Yoshio Marumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Marumoto. The network helps show where Yoshio Marumoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshio Marumoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 2 | |
| 2 | 2018 | 19 | |
| 3 | Systemic gemcitabine combined with hepatic arterial infusion chemotherapy with cisplatin, 5-fluorouracil, and isovorin for the treatment of advanced intrahepatic cholangiocarcinoma: a pilot study. | 2014 | 6 |
| 4 | 2013 | 162 | |
| 5 | 2013 | 5 | |
| 6 | 2013 | 8 | |
| 7 | 2008 | 19 | |
| 8 | 2006 | 12 | |
| 9 | 2006 | 27 | |
| 10 | 2006 | 369 | |
| 11 | 2005 | 38 |
About Yoshio Marumoto
Yoshio Marumoto is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine, having authored 11 papers that have together received 667 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (5 papers), Pancreatic function and diabetes (4 papers), Cancer Mechanisms and Therapy (2 papers), Fibroblast Growth Factor Research (2 papers), Hepatitis C virus research (2 papers), Cholesterol and Lipid Metabolism (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). The work is most often cited by research in Hepatology (396 citations), Genetics (197 citations) and Epidemiology (263 citations). Yoshio Marumoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Isao Sakaida, Shuji Terai, Tsuyoshi Ishikawa, Yohei Urata, Koji Aoyama, Kiwamu Okita, Takahiro Yamasaki, Koichi Uchida, Yasuhiko Fujii and Kaoru Ômori. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.